Navigation Links
Genome Technology Names 2008 'Tomorrow's PIs'
Date:12/8/2008

For the third year, Genome Technology magazine profiles the best up-and-coming young investigators, selected by the field's elite scientists

NEW YORK, Dec. 8 /PRNewswire/ -- Genome Technology magazine has named the 30 rising young stars who comprise its third annual "Tomorrow's PIs" special edition.

This issue offers readers a chance to see large-scale biological research through the eyes of some of the best and the brightest scientists who are poised to make significant contributions to their areas of interest.

This year-end special issue features 30 up-and-coming young researchers focusing on a range of research areas, from sequencing and gene expression to proteomics and translational research.

The young investigators were nominated by scientists who are established leaders in the field today, including Victor Ambros at the University of Massachusetts, Mary-Claire King at the University of Washington, Eddy Rubin from the Joint Genome Institute, Janet Thornton of the European Bioinformatics Institute, and Rick Wilson at Washington University, to name just a few.

The investigators chosen to be Tomorrow's PIs were selected for their innovative work and research in a discipline that's part of the systems biology field, as well as for being early in their careers as scientists.

Thanks to proceeds from advertisers, Genome Technology is able to offer travel stipend awards to the young scientists profiled in the issue.

    This year's Tomorrow's PIs are:

    Julius Brennecke, Cold Spring Harbor Laboratory
    Adriana Briscoe, University of California, Irvine
    Greg Cooper, University of Washington
    Li Ding, Washington University in St. Louis
    Laura Elnitski, National Human Genome Research Institute
    Paul Flicek, European Bioinformatics Institute
    Gad Getz, Broad Inst
'/>"/>
SOURCE Genome Technology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service
2. Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
3. J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology
4. ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies
5. Transgenomic Awarded SBIR Grant to Support Development of SURVEYOR(R) Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
6. A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Deutsche Bank Conference
8. Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
9. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to The Genome Center at Washington University School of Medicine in St. Louis
10. Complete Genomics Chooses Isilon IQ to Power Worlds First Complete Human Genome Sequencing Service
11. Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 2013  KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO ... Joseph as Chief Legal Officer.  Mr. Joseph brings ... and has worked in both public and private companies, ... (Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO ) "Don ... general counsel and senior executive and his knowledge and ...
(Date:6/17/2013)... 2013 zuChem Inc., a leading ... nutrition, announced today that the United States Patent ... - US 8,367,346 entitled “Methods for Production of ... for producing D-Mannitol." These two patents expand zuChem's ... food sweetener products from abundant, renewable feedstocks. ...
(Date:6/17/2013)... NY (PRWEB) June 17, 2013 With the ... the launch of the Chief Medical Officer Summit for Emerging ... will take place in San Francisco on November 4-5, ... For the first time, West Coast Chief Medical Officers at ... Dr. Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, ...
(Date:6/17/2013)... The ALS Therapy Development Institute (ALS TDI) will hold ... event on July 19-21, 2013. The Tri-State Trek is a three-day, ... to Greenwich, CT with the mission to ... disease). (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO ) ... passes through 46 communities and includes 12 rest stops, ...
Breaking Biology Technology:KaloBios Appoints Donald R. Joseph as Chief Legal Officer 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 4zuChem Receives Two Polyol Patents 2Chief Medical Officer Summit for Biotechs Goes West 2Chief Medical Officer Summit for Biotechs Goes West 3ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 2ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 3
... 3, 2011 EntreMed, Inc. (Nasdaq: ENMD ... treatment of cancer today announced the presentation of clinical ... platinum-resistant ovarian cancer patients.   The data were presented ... A. Matulonis, medical director of gynecologic oncology at Dana-Farber ...
... 2011 Asmacure Ltee, a clinical-stage biopharmaceutical ... for the treatment of asthma and other inflammatory diseases, ... chief executive officer.  With a solid foundation established at ... progresses its lead compound, a potential new treatment for ...
... KONG, June 3, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation ... plan to release financial results for the fourth quarter and ... 2011, after market close in the US.   ... ET on Monday, June 13, 2011 to discuss its financial ...
Cached Biology Technology:EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 2EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 3EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 4Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO 2Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO 3China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2011 Financial Results 2
(Date:6/14/2013)... World War II soldiers, "The White Cliffs of Dover" ... times. To geographers, the white cliffs mark the point ... scientists, the white cliffs are towering structures made of ... alga known as Emiliania huxleyi . "Ehux" is ... Even though the process by which the alga,s "armor" ...
(Date:6/14/2013)... OttawaJune 14, 2013Here,s a good reason to pay ... has published a paper from Ottawa researchers today, ... in the fight against cancer. The technique predicts ... cancer-killing, oncolytic viruses to overcome the natural defences ... infection. , "Oncolytic viruses are special in ...
(Date:6/13/2013)... The World Cultural Council is proud to announce that ... presentations, with its 30th Award Ceremony on Wednesday, 2nd ... and the Programme will be available shortly. , ... criteria for the Science Award of bringing "true benefit ... a scientific leader of several prestigious organizations, with significant ...
Breaking Biology News(10 mins):Chalking up a marine blooming alga: Genome fills a gap in the tree of life 2Chalking up a marine blooming alga: Genome fills a gap in the tree of life 3Chalking up a marine blooming alga: Genome fills a gap in the tree of life 4Using math to kill cancer cells 22013 World Cultural Council awards 22013 World Cultural Council awards 3
... major new review of scientific knowledge on kava a ... with calming effects has left unsolved the mystery of ... in the United States, Europe, and other Western cultures sometimes ... Chemical Research in Toxicology . Line Olsen and colleagues ...
... release is available in German and Spanish ... in Chile pose a higher threat to its neighbour, Argentina, ... University of Concepcin in Chile and the Helmholtz Centre for ... In particular, 22 non-native species which occur in Chile on ...
... , This release is available in German ... protects them against diseases. The early detection of pathogens and ... work as a protective shield. However, the pathogens that cause ... suppress the natural cell wall reaction in plants. "One particularly ...
Cached Biology News:Chile is more dangerous for Argentina than vice versa 2Chile is more dangerous for Argentina than vice versa 3TUM researchers discover a new switch in resistance to plant diseases 2
Carrier-Free Recombinant Human Flt-3/Flk-2 Ligand (Flt3/Flk2 Ligand, Flt3L, Flt3-L, Flk2L, Flk2-L) 100 ug...
... agent and DNA-topoisomersae II inhibitor (IC50 = 59.2 ... C 29 H 32 O 13 ... Store at: RT ... Soluble to 100 mM ...
NAP-2 (5C7)...
golgi reassembly stacking protein 2, 55kDa...
Biology Products: